Drug Profile
Research programme: estrogen-related receptor alpha modulators - GlaxoSmithKline
Alternative Names: GSK 0609Latest Information Update: 19 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Small molecules
- Mechanism of Action ERRalpha estrogen-related receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Feb 2011 No development reported - Preclinical for Cancer in USA (unspecified route)
- 18 Jun 2008 Preclinical trials in Cancer in USA (unspecified route)